StockNews.AI
SCPX
StockNews.AI
9 hrs

Scorpius Holdings Cancels Planned Reverse Stock Split

1. Scorpius Holdings canceled its planned 1-for-20 reverse stock split. 2. The company focuses on biologic programs and high-quality biomanufacturing. 3. Scorpius operates state-of-the-art facilities in San Antonio, TX.

3 mins saved
Full Article

FAQ

Why Bullish?

A canceled reverse split is often perceived positively by investors. Similar cases have historically led to stock price increases.

How important is it?

The cancellation of the reverse split can stabilize investor sentiment and boost confidence.

Why Short Term?

The immediate sentiment shift may lead to quick trading actions. Investor reactions to stock splits can cause rapid price movements.

Related Companies

January 17, 2025 15:13 ET  | Source: Scorpius Holdings, Inc. DURHAM, N.C., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced that the Company’s planned 1-for-20 reverse stock split (the “Reverse Stock Split”) of its common stock (the “Common Stock”) that was announced yesterday, will not be effectuated. Scorpius Holdings, Inc. Scorpius Holdings, Inc. is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic programs to the clinic and beyond. Scorpius offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the-art facilities in San Antonio, TX. With an experienced team and new, purpose-built U.S. facilities, Scorpius is dedicated to transparent collaboration and flexible, high-quality biologics biomanufacturing. For more information, please visit www.scorpiusbiologics.com. Media and Investor Relations ContactDavid Waldman+1 919 289 4017ir@scorpiusbiologics.com

Related News